The global market for Polymer Microfluidic Chips for Pharmaceuticals was valued at US$ 276 million in the year 2024 and is projected to reach a revised size of US$ 590 million by 2031, growing at a CAGR of 11.6% during the forecast period.
Polymer microfluidic chips used in pharmaceuticals are miniaturized devices that integrate functions such as microfluidic channels, reaction chambers, and detection elements, and are usually made of polymer materials. This chip uses micro-nano processing technology to accurately construct fluid channels and reaction areas at the micrometer scale, achieving precise control and operation of microfluids. In the pharmaceutical field, polymer microfluidic chips have unique advantages, such as high throughput, high efficiency, low consumption, easy integration and automation, etc., providing strong technical support for drug development, drug screening, drug synthesis analysis, drug delivery system research, etc. Specifically, polymer microfluidic chips used for pharmaceuticals can simulate the environment in the body, carry out complex biochemical reactions and drug evaluation, thereby accelerating the development process of new drugs. They can efficiently process and analyze drug candidate molecules, evaluate their key parameters such as biological activity, pharmacokinetic properties and toxicity, and help researchers screen out potential drug candidates. In addition, microfluidic chips can also be used in the study of drug delivery systems to improve the efficacy and safety of drugs by precisely controlling the release rate and targeting of drugs.
With the continuous advancement of biotechnology and micro-nano processing technology, polymer microfluidic chips are increasingly used in the pharmaceutical field, and the market size continues to expand. Due to their low cost, good flexibility and easy manufacturing, they occupy an important share in the pharmaceutical market. The application of polymer microfluidic chips in the pharmaceutical field mainly includes drug screening, drug synthesis analysis, drug delivery system research, etc. These applications not only improve the efficiency and accuracy of drug research and development, but also reduce research and development costs. In terms of drug screening, microfluidic chips can simulate the environment in the body, efficiently evaluate the activity and efficacy of drug candidates, and provide strong support for the development of new drugs. In the study of drug delivery systems, microfluidic chip technology helps to develop new drug delivery carriers and improve the targeting and bioavailability of drugs. In summary, the market for polymer microfluidic chips used in pharmaceuticals is in a rapid development stage, and in the future, the market is expected to continue to maintain a high growth trend.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polymer Microfluidic Chips for Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymer Microfluidic Chips for Pharmaceuticals.
The Polymer Microfluidic Chips for Pharmaceuticals market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polymer Microfluidic Chips for Pharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymer Microfluidic Chips for Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Fluidigm
Micronit Microfluidics
PerkinElmer
Danaher
microfluidic ChipShop
Dolomite Microfluidics
Precigenome
Enplas
Ufluidix
Hicomp Microtech
MiNAN Technologies
Atrandi Biosciences
Wenhao Microfludic Technology
Suzhou Hanguang Micro-Nano Technology
Dingxu Microcontrol
by Type
Polydimethylsiloxane (PDMS) Microfluidic Chip
Polymethyl Methacrylate (PMMA) Microfluidic Chip
Polycarbonate (PC) Microfluidic Chip
Other
by Application
Drug Screening
Drug Synthesis Analysis
Drug Delivery System Research
Other
Production by Region
North America
Europe
China
Japan
South Korea
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymer Microfluidic Chips for Pharmaceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Polymer Microfluidic Chips for Pharmaceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Polymer Microfluidic Chips for Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Polymer Microfluidic Chips for Pharmaceuticals Market Overview
1.1 Product Definition
1.2 Polymer Microfluidic Chips for Pharmaceuticals by Type
1.2.1 Global Polymer Microfluidic Chips for Pharmaceuticals Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Polydimethylsiloxane (PDMS) Microfluidic Chip
1.2.3 Polymethyl Methacrylate (PMMA) Microfluidic Chip
1.2.4 Polycarbonate (PC) Microfluidic Chip
1.2.5 Other
1.3 Polymer Microfluidic Chips for Pharmaceuticals by Application
1.3.1 Global Polymer Microfluidic Chips for Pharmaceuticals Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Drug Screening
1.3.3 Drug Synthesis Analysis
1.3.4 Drug Delivery System Research
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Polymer Microfluidic Chips for Pharmaceuticals Production Estimates and Forecasts (2020-2031)
1.4.4 Global Polymer Microfluidic Chips for Pharmaceuticals Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production Market Share by Manufacturers (2020-2025)
2.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Polymer Microfluidic Chips for Pharmaceuticals, Industry Ranking, 2023 VS 2024
2.4 Global Polymer Microfluidic Chips for Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Polymer Microfluidic Chips for Pharmaceuticals Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Polymer Microfluidic Chips for Pharmaceuticals, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Polymer Microfluidic Chips for Pharmaceuticals, Product Offered and Application
2.8 Global Key Manufacturers of Polymer Microfluidic Chips for Pharmaceuticals, Date of Enter into This Industry
2.9 Polymer Microfluidic Chips for Pharmaceuticals Market Competitive Situation and Trends
2.9.1 Polymer Microfluidic Chips for Pharmaceuticals Market Concentration Rate
2.9.2 Global 5 and 10 Largest Polymer Microfluidic Chips for Pharmaceuticals Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Polymer Microfluidic Chips for Pharmaceuticals Production by Region
3.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value by Region (2020-2031)
3.2.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Polymer Microfluidic Chips for Pharmaceuticals by Region (2026-2031)
3.3 Global Polymer Microfluidic Chips for Pharmaceuticals Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Polymer Microfluidic Chips for Pharmaceuticals Production Volume by Region (2020-2031)
3.4.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Polymer Microfluidic Chips for Pharmaceuticals by Region (2026-2031)
3.5 Global Polymer Microfluidic Chips for Pharmaceuticals Market Price Analysis by Region (2020-2025)
3.6 Global Polymer Microfluidic Chips for Pharmaceuticals Production and Value, Year-over-Year Growth
3.6.1 North America Polymer Microfluidic Chips for Pharmaceuticals Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Polymer Microfluidic Chips for Pharmaceuticals Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Polymer Microfluidic Chips for Pharmaceuticals Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Polymer Microfluidic Chips for Pharmaceuticals Production Value Estimates and Forecasts (2020-2031)
3.6.5 South Korea Polymer Microfluidic Chips for Pharmaceuticals Production Value Estimates and Forecasts (2020-2031)
4 Polymer Microfluidic Chips for Pharmaceuticals Consumption by Region
4.1 Global Polymer Microfluidic Chips for Pharmaceuticals Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Polymer Microfluidic Chips for Pharmaceuticals Consumption by Region (2020-2031)
4.2.1 Global Polymer Microfluidic Chips for Pharmaceuticals Consumption by Region (2020-2025)
4.2.2 Global Polymer Microfluidic Chips for Pharmaceuticals Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Polymer Microfluidic Chips for Pharmaceuticals Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Polymer Microfluidic Chips for Pharmaceuticals Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Polymer Microfluidic Chips for Pharmaceuticals Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Polymer Microfluidic Chips for Pharmaceuticals Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific Polymer Microfluidic Chips for Pharmaceuticals Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Polymer Microfluidic Chips for Pharmaceuticals Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Polymer Microfluidic Chips for Pharmaceuticals Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Polymer Microfluidic Chips for Pharmaceuticals Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Israel
5 Segment by Type
5.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production by Type (2020-2031)
5.1.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production by Type (2020-2025)
5.1.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production by Type (2026-2031)
5.1.3 Global Polymer Microfluidic Chips for Pharmaceuticals Production Market Share by Type (2020-2031)
5.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value by Type (2020-2031)
5.2.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value by Type (2020-2025)
5.2.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value by Type (2026-2031)
5.2.3 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value Market Share by Type (2020-2031)
5.3 Global Polymer Microfluidic Chips for Pharmaceuticals Price by Type (2020-2031)
6 Segment by Application
6.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production by Application (2020-2031)
6.1.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production by Application (2020-2025)
6.1.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production by Application (2026-2031)
6.1.3 Global Polymer Microfluidic Chips for Pharmaceuticals Production Market Share by Application (2020-2031)
6.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value by Application (2020-2031)
6.2.1 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value by Application (2020-2025)
6.2.2 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value by Application (2026-2031)
6.2.3 Global Polymer Microfluidic Chips for Pharmaceuticals Production Value Market Share by Application (2020-2031)
6.3 Global Polymer Microfluidic Chips for Pharmaceuticals Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Agilent Technologies
7.1.1 Agilent Technologies Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.1.2 Agilent Technologies Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.1.3 Agilent Technologies Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Agilent Technologies Main Business and Markets Served
7.1.5 Agilent Technologies Recent Developments/Updates
7.2 Fluidigm
7.2.1 Fluidigm Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.2.2 Fluidigm Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.2.3 Fluidigm Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Fluidigm Main Business and Markets Served
7.2.5 Fluidigm Recent Developments/Updates
7.3 Micronit Microfluidics
7.3.1 Micronit Microfluidics Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.3.2 Micronit Microfluidics Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.3.3 Micronit Microfluidics Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Micronit Microfluidics Main Business and Markets Served
7.3.5 Micronit Microfluidics Recent Developments/Updates
7.4 PerkinElmer
7.4.1 PerkinElmer Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.4.2 PerkinElmer Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.4.3 PerkinElmer Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.4.4 PerkinElmer Main Business and Markets Served
7.4.5 PerkinElmer Recent Developments/Updates
7.5 Danaher
7.5.1 Danaher Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.5.2 Danaher Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.5.3 Danaher Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Danaher Main Business and Markets Served
7.5.5 Danaher Recent Developments/Updates
7.6 microfluidic ChipShop
7.6.1 microfluidic ChipShop Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.6.2 microfluidic ChipShop Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.6.3 microfluidic ChipShop Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.6.4 microfluidic ChipShop Main Business and Markets Served
7.6.5 microfluidic ChipShop Recent Developments/Updates
7.7 Dolomite Microfluidics
7.7.1 Dolomite Microfluidics Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.7.2 Dolomite Microfluidics Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.7.3 Dolomite Microfluidics Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Dolomite Microfluidics Main Business and Markets Served
7.7.5 Dolomite Microfluidics Recent Developments/Updates
7.8 Precigenome
7.8.1 Precigenome Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.8.2 Precigenome Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.8.3 Precigenome Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Precigenome Main Business and Markets Served
7.8.5 Precigenome Recent Developments/Updates
7.9 Enplas
7.9.1 Enplas Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.9.2 Enplas Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.9.3 Enplas Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Enplas Main Business and Markets Served
7.9.5 Enplas Recent Developments/Updates
7.10 Ufluidix
7.10.1 Ufluidix Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.10.2 Ufluidix Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.10.3 Ufluidix Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Ufluidix Main Business and Markets Served
7.10.5 Ufluidix Recent Developments/Updates
7.11 Hicomp Microtech
7.11.1 Hicomp Microtech Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.11.2 Hicomp Microtech Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.11.3 Hicomp Microtech Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Hicomp Microtech Main Business and Markets Served
7.11.5 Hicomp Microtech Recent Developments/Updates
7.12 MiNAN Technologies
7.12.1 MiNAN Technologies Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.12.2 MiNAN Technologies Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.12.3 MiNAN Technologies Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.12.4 MiNAN Technologies Main Business and Markets Served
7.12.5 MiNAN Technologies Recent Developments/Updates
7.13 Atrandi Biosciences
7.13.1 Atrandi Biosciences Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.13.2 Atrandi Biosciences Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.13.3 Atrandi Biosciences Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Atrandi Biosciences Main Business and Markets Served
7.13.5 Atrandi Biosciences Recent Developments/Updates
7.14 Wenhao Microfludic Technology
7.14.1 Wenhao Microfludic Technology Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.14.2 Wenhao Microfludic Technology Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.14.3 Wenhao Microfludic Technology Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Wenhao Microfludic Technology Main Business and Markets Served
7.14.5 Wenhao Microfludic Technology Recent Developments/Updates
7.15 Suzhou Hanguang Micro-Nano Technology
7.15.1 Suzhou Hanguang Micro-Nano Technology Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.15.2 Suzhou Hanguang Micro-Nano Technology Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.15.3 Suzhou Hanguang Micro-Nano Technology Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Suzhou Hanguang Micro-Nano Technology Main Business and Markets Served
7.15.5 Suzhou Hanguang Micro-Nano Technology Recent Developments/Updates
7.16 Dingxu Microcontrol
7.16.1 Dingxu Microcontrol Polymer Microfluidic Chips for Pharmaceuticals Company Information
7.16.2 Dingxu Microcontrol Polymer Microfluidic Chips for Pharmaceuticals Product Portfolio
7.16.3 Dingxu Microcontrol Polymer Microfluidic Chips for Pharmaceuticals Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Dingxu Microcontrol Main Business and Markets Served
7.16.5 Dingxu Microcontrol Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Polymer Microfluidic Chips for Pharmaceuticals Industry Chain Analysis
8.2 Polymer Microfluidic Chips for Pharmaceuticals Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Polymer Microfluidic Chips for Pharmaceuticals Production Mode & Process Analysis
8.4 Polymer Microfluidic Chips for Pharmaceuticals Sales and Marketing
8.4.1 Polymer Microfluidic Chips for Pharmaceuticals Sales Channels
8.4.2 Polymer Microfluidic Chips for Pharmaceuticals Distributors
8.5 Polymer Microfluidic Chips for Pharmaceuticals Customer Analysis
9 Polymer Microfluidic Chips for Pharmaceuticals Market Dynamics
9.1 Polymer Microfluidic Chips for Pharmaceuticals Industry Trends
9.2 Polymer Microfluidic Chips for Pharmaceuticals Market Drivers
9.3 Polymer Microfluidic Chips for Pharmaceuticals Market Challenges
9.4 Polymer Microfluidic Chips for Pharmaceuticals Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Agilent Technologies
Fluidigm
Micronit Microfluidics
PerkinElmer
Danaher
microfluidic ChipShop
Dolomite Microfluidics
Precigenome
Enplas
Ufluidix
Hicomp Microtech
MiNAN Technologies
Atrandi Biosciences
Wenhao Microfludic Technology
Suzhou Hanguang Micro-Nano Technology
Dingxu Microcontrol
听
听
*If Applicable.
